Interestingly, MYH3 was also shown to be expressed in bone, which the authors state may explain the effects of MYH3 variants on both skeletal muscle and bone, particularly for patients with spondylocarpotarsal synostosis syndrome and bony fusions [61]. Here, MYH3 is linked to Spondylocarpotarsal synostosis.